UC-San Francisco: Cancer Researcher Thomas Martin Receives $4.6 Million CIRM Grant
January 04, 2024
January 04, 2024
SAN FRANCISCO, California, Jan. 4 (TNSres) -- The University of California San Francisco campus issued the following news release:
* * *
Funding will support production of next generation CAR T cell therapy for multiple myeloma.
* * *
UC San Francisco's Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell th . . .
* * *
Funding will support production of next generation CAR T cell therapy for multiple myeloma.
* * *
UC San Francisco's Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T cell th . . .